Vytrus Biotech Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Vytrus Biotech.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Personal Products earnings growth8.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated07 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:V5P - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20245N/AN/AN/A1
12/31/20235101N/A
9/30/20235101N/A
6/30/202351-10N/A
3/31/20235100N/A
12/31/20224101N/A
9/30/20224101N/A
6/30/20224100N/A
3/31/20224100N/A
12/31/20214000N/A
12/31/20202000N/A
12/31/201920N/AN/AN/A
12/31/201810N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if V5P's forecast earnings growth is above the savings rate (0.8%).

Earnings vs Market: Insufficient data to determine if V5P's earnings are forecast to grow faster than the German market

High Growth Earnings: Insufficient data to determine if V5P's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if V5P's revenue is forecast to grow faster than the German market.

High Growth Revenue: Insufficient data to determine if V5P's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if V5P's Return on Equity is forecast to be high in 3 years time


Discover growth companies